• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

In vitro activity of the novel des-F(6) quinolone BMS-284756 against genetically characterized clinical streptococcal isolates, including isolates with reduced quinolone susceptibility.

作者信息

Schmitz F-J, Milatovic D, Boos M, Mayer S, Fluit A C

出版信息

J Antimicrob Chemother. 2002 Apr;49(4):698-701. doi: 10.1093/jac/49.4.698.

DOI:10.1093/jac/49.4.698
PMID:11909849
Abstract
摘要

相似文献

1
In vitro activity of the novel des-F(6) quinolone BMS-284756 against genetically characterized clinical streptococcal isolates, including isolates with reduced quinolone susceptibility.新型去F(6)喹诺酮BMS-284756对基因特征明确的临床链球菌分离株的体外活性，包括对喹诺酮敏感性降低的分离株。
J Antimicrob Chemother. 2002 Apr;49(4):698-701. doi: 10.1093/jac/49.4.698.
2
The in vitro activity of BMS-284756, a new des-fluorinated quinolone.新型去氟喹诺酮类药物BMS-284756的体外活性
J Antimicrob Chemother. 2002 Jan;49(1):177-84. doi: 10.1093/jac/49.1.177.
3
Increased in vitro activity of the novel des-fluoro(6) quinolone BMS-284756 against genetically defined clinical isolates of Staphylococcus aureus.新型去氟（6）喹诺酮BMS-284756对基因明确的金黄色葡萄球菌临床分离株的体外活性增强。
J Antimicrob Chemother. 2002 Feb;49(2):283-7. doi: 10.1093/jac/49.2.283.
4
Antimicrobial activity of BMS 284756, a novel des-fluoro (6) quinolone and seven fluoroquinolones against Streptococcus pneumoniae.新型去氟（6）喹诺酮类药物BMS 284756及七种氟喹诺酮类药物对肺炎链球菌的抗菌活性
Clin Microbiol Infect. 2001 Oct;7(10):572-3.
5
In vitro activities of novel des-fluoro(6) quinolone BMS-284756 against mutants of Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus selected with different quinolones.新型去氟（6）喹诺酮BMS-284756对用不同喹诺酮类药物筛选出的肺炎链球菌、化脓性链球菌和金黄色葡萄球菌突变株的体外活性
Antimicrob Agents Chemother. 2002 Mar;46(3):934-5. doi: 10.1128/AAC.46.3.934-935.2002.
6
Impact of AUC/MIC ratios on the pharmacodynamics of the des-F(6) quinolone garenoxacin (BMS-284756) is similar to other fluoroquinolones.AUC/MIC 比值对去氟（6）喹诺酮类药物加替沙星（BMS-284756）药效学的影响与其他氟喹诺酮类药物相似。
J Antimicrob Chemother. 2003 Jan;51(1):199-202. doi: 10.1093/jac/dkg017.
7
In vitro activities of BMS-284756 against Chlamydia trachomatis and recent clinical isolates of Chlamydia pneumoniae.BMS-284756对沙眼衣原体及肺炎衣原体近期临床分离株的体外活性
Antimicrob Agents Chemother. 2002 Feb;46(2):517-8. doi: 10.1128/AAC.46.2.517-518.2002.
8
Activity and spectrum of BMS 284756, a new des-F (6) quinolone, tested against strains of ciprofloxacin-resistant Gram-positive cocci.
Diagn Microbiol Infect Dis. 2001 Feb;39(2):133-5. doi: 10.1016/s0732-8893(00)00233-9.
9
Mechanism of action of the des-F(6) quinolone BMS-284756 measured by supercoiling inhibition and cleavable complex assays.通过超螺旋抑制和可切割复合物分析测定去-F(6)喹诺酮BMS-284756的作用机制。
Antimicrob Agents Chemother. 2001 Dec;45(12):3660-2. doi: 10.1128/AAC.45.12.3660-3662.2001.
10
Activities of BMS 284756 (T-3811) against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae isolates from SENTRY antimicrobial surveillance program medical centers in Latin America (1999).BMS 284756（T - 3811）对来自拉丁美洲哨兵抗菌监测项目医疗中心（1999年）分离出的流感嗜血杆菌、卡他莫拉菌和肺炎链球菌的活性。
Antimicrob Agents Chemother. 2001 May;45(5):1463-6. doi: 10.1128/AAC.45.5.1463-1466.2001.

引用本文的文献

1
Alternative strategies for proof-of-principle studies of antibacterial agents.抗菌剂原理验证研究的替代策略。
Antimicrob Agents Chemother. 2014 Aug;58(8):4257-63. doi: 10.1128/AAC.02473-14. Epub 2014 May 27.
2
Emergence of quinolone resistance among viridans group streptococci isolated from the oropharynx of neutropenic peripheral blood stem cell transplant patients receiving quinolone antimicrobial prophylaxis.在接受喹诺酮类抗菌药物预防治疗的中性粒细胞减少外周血干细胞移植患者的口咽部分离出的草绿色链球菌中出现喹诺酮耐药性。
Eur J Clin Microbiol Infect Dis. 2005 Dec;24(12):832-8. doi: 10.1007/s10096-005-0037-3.
3
In vitro antibacterial activity and pharmacodynamics of new quinolones.
新型喹诺酮类药物的体外抗菌活性及药效学
Eur J Clin Microbiol Infect Dis. 2003 Apr;22(4):203-21. doi: 10.1007/s10096-003-0907-5. Epub 2003 Apr 1.